INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 84 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $388 | +77.2% | 12,280 | +128.3% | 0.04% | +39.3% |
Q2 2023 | $219 | -100.0% | 5,380 | -33.8% | 0.03% | -37.8% |
Q3 2022 | $455,000 | +80.6% | 8,130 | +134.3% | 0.04% | +50.0% |
Q1 2022 | $252,000 | +50.9% | 3,470 | -66.8% | 0.03% | -6.2% |
Q2 2017 | $167,000 | – | 10,454 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |